Skip to content

The effect of marshmallow and hydrocortisone ointment in children with atopic dermatitis

The evaluation of efficacy of marshmallow ointment (1%) in comparison with topical hydrocortisone (1%) on children with atopic dermatitis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017020831205N2
Enrollment
22
Registered
2017-04-03
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis. Atopic dermatitis

Interventions

Intervention 1: Intervention group 1: Receive marshmallow ointment (1%) three times a day. This ointment produced by the School of Pharmacy, Shahid Beheshti University of Medical Sciences and Health
Treatment - Drugs
Intervention group 1: Receive marshmallow ointment (1%) three times a day. This ointment produced by the School of Pharmacy, Shahid Beheshti University of Medical Sciences and Health Services in Teh
control group: not used
Intervention group 2: Receive hydrocortisone ointment (1%) three times a day. This ointment produced by the School of Pharmacy, Shahid Beheshti University of Medical Sciences and Health Services in T

Sponsors

Vice Chancellor for research of Shahid Beheshti University of Medical Sciences and Health Services,
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Months to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: The age of patients ranged from 3 months to 12 year; The patient has no history of contact dermatitis to prescription drugs; Patients with acute infection is localized; According to the SCORAD severity of the disease is between 50-25. Exclusion criteria: changes in the level and score of SCORAD

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Disease severity based on the criteria SCOARD. Timepoint: the first day intervention, the seventh day intervention, the thirtieth day intervention. Method of measurement: Visual Analogue Scale.

Secondary

MeasureTime frame
Not used. Timepoint: not used. Method of measurement: not used.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohsen Naseri

Traditional Iranian Medicine Clinical Trial

naserishahed@yahoo.com, r.jafari.hajati@gmail.com+98 21 6646 4320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026